MX2016009965A - Produccion de alta titulacion de vectores virales adenoasociados. - Google Patents
Produccion de alta titulacion de vectores virales adenoasociados.Info
- Publication number
- MX2016009965A MX2016009965A MX2016009965A MX2016009965A MX2016009965A MX 2016009965 A MX2016009965 A MX 2016009965A MX 2016009965 A MX2016009965 A MX 2016009965A MX 2016009965 A MX2016009965 A MX 2016009965A MX 2016009965 A MX2016009965 A MX 2016009965A
- Authority
- MX
- Mexico
- Prior art keywords
- adeno
- associated viral
- viral vectors
- high titer
- vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Abstract
La invención se refiere a vectores virales adenoasociados (AVV), para producir líneas celulares para la producción de vectores AAV y a métodos para producir esos vectores. Más específicamente la invención se refiere a líneas celulares productoras adaptadas para aumentar el título de esos vectores, y métodos para producir los vectores AAV usando las líneas celulares productoras.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201401707A GB201401707D0 (en) | 2014-01-31 | 2014-01-31 | Adeno-associated viral vectors |
PCT/GB2015/050240 WO2015114365A1 (en) | 2014-01-31 | 2015-01-30 | High titer production of adeno-associated viral vectors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016009965A true MX2016009965A (es) | 2017-06-14 |
Family
ID=50344213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016009965A MX2016009965A (es) | 2014-01-31 | 2015-01-30 | Produccion de alta titulacion de vectores virales adenoasociados. |
Country Status (13)
Country | Link |
---|---|
US (1) | US10035985B2 (es) |
EP (1) | EP3099788A1 (es) |
JP (1) | JP2017506885A (es) |
KR (1) | KR20160137985A (es) |
CN (1) | CN105980551A (es) |
AU (1) | AU2015212563A1 (es) |
BR (1) | BR112016015629A2 (es) |
CA (1) | CA2934774A1 (es) |
GB (1) | GB201401707D0 (es) |
IL (1) | IL246588A0 (es) |
MX (1) | MX2016009965A (es) |
SG (1) | SG11201605848TA (es) |
WO (1) | WO2015114365A1 (es) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9217155B2 (en) | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
DK2826860T3 (en) | 2010-04-23 | 2018-12-03 | Univ Massachusetts | CNS targeting AAV vectors and methods for their use |
WO2011133874A1 (en) | 2010-04-23 | 2011-10-27 | University Of Massachusetts | Multicistronic expression constructs |
WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
US10072251B2 (en) | 2014-02-19 | 2018-09-11 | University Of Massachusetts | Recombinant AAVS having useful transcytosis properties |
EP3750907A3 (en) | 2014-03-18 | 2021-04-28 | University of Massachusetts | Raav-based compositions and methods for treating amyotrophic lateral sclerosis |
WO2015187825A2 (en) | 2014-06-03 | 2015-12-10 | University Of Massachusetts | Compositions and methods for modulating dysferlin expression |
WO2015191508A1 (en) | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
WO2016054554A1 (en) | 2014-10-03 | 2016-04-07 | University Of Massachusetts | Heterologous targeting peptide grafted aavs |
CN107073051B (zh) | 2014-10-21 | 2021-08-24 | 马萨诸塞大学 | 重组aav变体及其用途 |
MX2017005834A (es) | 2014-11-05 | 2017-11-17 | Voyager Therapeutics Inc | Polinucleotidos aad para el tratamiento de la enfermedad de parkinson. |
CN112375760A (zh) | 2014-11-14 | 2021-02-19 | 沃雅戈治疗公司 | 调节性多核苷酸 |
AU2015346162B2 (en) | 2014-11-14 | 2022-02-10 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
EP3256170B1 (en) | 2015-02-13 | 2020-09-23 | University of Massachusetts | Compositions and methods for transient delivery of nucleases |
US11046955B2 (en) | 2015-04-24 | 2021-06-29 | University Of Massachusetts | Modified AAV constructs and uses thereof |
DK3364997T3 (da) | 2015-10-22 | 2024-04-22 | Univ Massachusetts | Aspartoacylase genterapi til behandling af canavans sygdom |
CA3002980A1 (en) | 2015-10-22 | 2017-04-27 | University Of Massachusetts | Prostate-targeting adeno-associated virus serotype vectors |
EP3365357B1 (en) | 2015-10-23 | 2024-02-14 | President and Fellows of Harvard College | Evolved cas9 proteins for gene editing |
EP4066862A1 (en) * | 2015-11-05 | 2022-10-05 | The General Hospital Corporation | Intrathecal delivery of nucleic acid sequences encoding abcd1 for treatment of adrenomyeloneuropathy |
US11826433B2 (en) | 2016-02-02 | 2023-11-28 | University Of Massachusetts | Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system |
CA3012344A1 (en) | 2016-02-12 | 2017-08-17 | University Of Massachusetts | Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization |
WO2017176929A1 (en) | 2016-04-05 | 2017-10-12 | University Of Massachusetts | Compositions and methods for selective inhibition of grainyhead-like protein expression |
US11413356B2 (en) | 2016-04-15 | 2022-08-16 | University Of Massachusetts | Methods and compositions for treating metabolic imbalance |
EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR THE TREATMENT OF DISEASES |
SG11201809699XA (en) | 2016-05-18 | 2018-12-28 | Voyager Therapeutics Inc | Modulatory polynucleotides |
RU2764587C2 (ru) | 2016-05-18 | 2022-01-18 | Вояджер Терапьютикс, Инк. | Способы и композиции для лечения хореи гентингтона |
US11882815B2 (en) | 2016-06-15 | 2024-01-30 | University Of Massachusetts | Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells |
AU2017306676B2 (en) | 2016-08-03 | 2024-02-22 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
TN2019000047A1 (en) | 2016-08-15 | 2020-07-15 | Genzyme Corp | Methods for detecting aav |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US10457940B2 (en) | 2016-09-22 | 2019-10-29 | University Of Massachusetts | AAV treatment of Huntington's disease |
US11578340B2 (en) | 2016-10-13 | 2023-02-14 | University Of Massachusetts | AAV capsid designs |
SG11201903089RA (en) | 2016-10-14 | 2019-05-30 | Harvard College | Aav delivery of nucleobase editors |
WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
SG11201909868YA (en) | 2017-05-05 | 2019-11-28 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
JP2020518258A (ja) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | 筋萎縮性側索硬化症(als)治療組成物および方法 |
WO2018208972A1 (en) | 2017-05-09 | 2018-11-15 | University Of Massachusetts | Methods of treating amyotrophic lateral sclerosis (als) |
WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
CN111132626B (zh) | 2017-07-17 | 2024-01-30 | 沃雅戈治疗公司 | 轨迹阵列引导系统 |
JP2020534795A (ja) | 2017-07-28 | 2020-12-03 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物 |
KR20200044793A (ko) | 2017-08-03 | 2020-04-29 | 보이저 테라퓨틱스, 인크. | Aav의 전달을 위한 조성물 및 방법 |
WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
WO2019060686A1 (en) | 2017-09-22 | 2019-03-28 | University Of Massachusetts | NEW DUAL EXPRESSION VECTORS OF SOD1 AND USES THEREOF |
EP3694988A4 (en) * | 2017-10-10 | 2021-07-14 | NantBio, Inc. | MODIFIED EC7 CELLS WITH LOW TOXICITY TO VIRAL PRODUCTION LOADS |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
JP2021502060A (ja) | 2017-10-16 | 2021-01-28 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | 筋萎縮性側索硬化症(als)の治療 |
WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
JP2022526908A (ja) | 2019-03-19 | 2022-05-27 | ザ ブロード インスティテュート,インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
SG11202110904PA (en) * | 2019-04-12 | 2021-10-28 | Ultragenyx Pharmaceutical Inc | Engineered producer cell lines and methods of making and using the same |
US20220186193A1 (en) * | 2019-04-12 | 2022-06-16 | Massachusetts Eye & Ear Infirmary | METHODS AND COMPOSITIONS FOR IMPROVING THE ASSEMBLY OF ADENO-ASSOCIATED VIRUSES (AAVs) |
US20220228129A1 (en) * | 2019-04-26 | 2022-07-21 | The Regents Of The University Of California | Cells for enhanced production of adeno-associated virus |
CN110184297A (zh) * | 2019-05-27 | 2019-08-30 | 广州派真生物技术有限公司 | 一种表达shRNA的AAV辅助包装载体、构建筛选方法和应用 |
AU2021267940A1 (en) | 2020-05-08 | 2022-12-08 | President And Fellows Of Harvard College | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003046142A2 (en) | 2001-11-26 | 2003-06-05 | Avigen, Inc. | Methods for producing stocks of recombinant aav virions |
PT1625210E (pt) * | 2003-05-21 | 2011-03-15 | Genzyme Corp | Métodos para produzir preparações de vírions de aav recombinantes substancialmente livres de capsídeos vazios |
WO2008026946A2 (en) | 2006-08-30 | 2008-03-06 | Genesis Research And Development Corporation Limited | Compositions and methods for the treatment and prevention of neoplastic disorders |
CN105838737A (zh) | 2010-01-28 | 2016-08-10 | 费城儿童医院 | 用于病毒载体纯化的可扩缩生产平台和用于基因治疗中的如此纯化的病毒载体 |
US9585380B2 (en) * | 2011-09-02 | 2017-03-07 | Temple University—Of the Commonwealth System of Higher Education | SSAT mRNA translation repression and activation |
US8697359B1 (en) * | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
-
2014
- 2014-01-31 GB GB201401707A patent/GB201401707D0/en not_active Ceased
-
2015
- 2015-01-30 CA CA2934774A patent/CA2934774A1/en not_active Abandoned
- 2015-01-30 SG SG11201605848TA patent/SG11201605848TA/en unknown
- 2015-01-30 BR BR112016015629A patent/BR112016015629A2/pt not_active IP Right Cessation
- 2015-01-30 WO PCT/GB2015/050240 patent/WO2015114365A1/en active Application Filing
- 2015-01-30 JP JP2016547187A patent/JP2017506885A/ja active Pending
- 2015-01-30 EP EP15702840.8A patent/EP3099788A1/en not_active Withdrawn
- 2015-01-30 AU AU2015212563A patent/AU2015212563A1/en not_active Abandoned
- 2015-01-30 KR KR1020167024086A patent/KR20160137985A/ko not_active Application Discontinuation
- 2015-01-30 US US15/113,270 patent/US10035985B2/en not_active Expired - Fee Related
- 2015-01-30 CN CN201580006117.3A patent/CN105980551A/zh active Pending
- 2015-01-30 MX MX2016009965A patent/MX2016009965A/es unknown
-
2016
- 2016-07-04 IL IL246588A patent/IL246588A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2015212563A1 (en) | 2016-07-14 |
SG11201605848TA (en) | 2016-08-30 |
IL246588A0 (en) | 2016-08-31 |
US20170029785A1 (en) | 2017-02-02 |
BR112016015629A2 (pt) | 2017-10-24 |
EP3099788A1 (en) | 2016-12-07 |
US10035985B2 (en) | 2018-07-31 |
CA2934774A1 (en) | 2015-08-06 |
CN105980551A (zh) | 2016-09-28 |
JP2017506885A (ja) | 2017-03-16 |
WO2015114365A1 (en) | 2015-08-06 |
KR20160137985A (ko) | 2016-12-02 |
GB201401707D0 (en) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016009965A (es) | Produccion de alta titulacion de vectores virales adenoasociados. | |
PH12019502283A1 (en) | Anti-lag3 antibodies | |
PH12016501700A1 (en) | Combination therapies with anti-cd38 antibodies | |
AU2024202215A1 (en) | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia | |
PH12018501159A1 (en) | Composition and methods for immunooncology | |
IL288784A (en) | Antibodies against garp, nucleotides encoding them, and vectors, cells and preparations containing them, methods for their preparation and uses thereof | |
MX2019003489A (es) | Moleculas del receptor de envolvimiento quimerico. | |
PH12016501763A1 (en) | Multispecific antibodies | |
PH12017501042A1 (en) | Anti-cd38 antibodies for treatment of acute myeloid leukemia | |
PH12017500858A1 (en) | Mocrocyclic peptides useful as immunomodulators | |
MX2022016566A (es) | Composiciones que comprenden una caseina y metodos para producir las mismas. | |
EP3741849A3 (en) | Protease variants and polynucleotides encoding same | |
MX2017010405A (es) | Proceso y sistema para producir polipropiolactona. | |
MX2016002571A (es) | Regulador de ph de transduccion. | |
MX2015012401A (es) | Composiciones y metodos de alterar niveles de colesterol. | |
NZ726859A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
MX2021006732A (es) | Nanoemulsiones para bebidas producidas mediante un proceso de alto cizallamiento. | |
EA201790505A1 (ru) | Соединение, нацеленое на ил-23а и фно-альфа, и его применение | |
IN2014MU00455A (es) | ||
EA201791491A1 (ru) | Способы выделения тромбоцитов | |
CL2017000087A1 (es) | Un proceso novedoso para la purificación de rhu-gcsf | |
MX2019004182A (es) | Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al. | |
IN2014CH00151A (es) | ||
MX2016002027A (es) | Nuevos anticuerpos anti receptores iib fc-gama y usos de los mismos. | |
EA201692246A1 (ru) | Способ получения 2,6-диметилбензохинона |